C
SUPN icon

Covestor’s Supernus Pharmaceuticals SUPN Stock Holding History

Covestor’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45K Sell
867
-1,816
-68% -$92.5K 0.03% 774
2025
Q4 		$133K Buy
2,683
+374
+16% +$18.2K 0.07% 402
2025
Q3 		$110K Buy
2,309
+527
+30% +$21.2K 0.06% 528
2025
Q2 		$56K Buy
1,782
+798
+81% +$25.6K 0.03% 848
2025
Q1 		$32K Sell
984
-529
-35% -$18.7K 0.02% 1023
2024
Q4 		$55K Sell
1,513
-138
-8% -$4.86K 0.03% 824
2024
Q3 		$51K Sell
1,651
-6
-0.4% -$187 0.03% 871
2024
Q2 		$44K Sell
1,657
-1,045
-39% -$30.3K 0.03% 918
2024
Q1 		$92K Buy
2,702
+358
+15% +$10.7K 0.06% 597
2023
Q4 		$68K Sell
2,344
-6
-0.3% -$159 0.05% 717
2023
Q3 		$65K Buy
2,350
+1,257
+115% +$38.3K 0.05% 649
2023
Q2 		$33K Buy
1,093
+230
+27% +$8.05K 0.03% 953
2023
Q1 		$31K Buy
863
+858
+17,160% +$33K 0.03% 878
2022
Q4 		$0 Sell
5
-103
-95% -$3.58K ﹤0.01% 2587
2022
Q3 		$4K Buy
108
+99
+1,100% +$3.22K ﹤0.01% 1579
2022
Q2 		$0 Sell
9
-168
-95% -$4.81K ﹤0.01% 2352
2022
Q1 		$6K Buy
177
+25
+16% +$766 ﹤0.01% 1461
2021
Q4 		$4K Buy
+152
New +$4.61K 0.01% 1421

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Covestor's SUPN Position: Q1 2026 in Review

Covestor reduced its Supernus Pharmaceuticals (SUPN) stake by 68% in Q1 2026, selling an estimated $92.5K and leaving 867 shares worth $45K. The position accounts for 0.03% of the portfolio, ranked #774.

Covestor first reported a position in SUPN in Q4 2021 and has held it in 18 quarters since. The position peaked at $133K in Q4 2025. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Covestor held 867 shares of Supernus Pharmaceuticals worth $45K as of Q1 2026.
  • Covestor sold 1,816 Supernus Pharmaceuticals shares in Q1 2026, an estimated $92.5K.
  • Supernus Pharmaceuticals made up 0.03% of Covestor's portfolio in Q1 2026, its #774 holding.
  • Covestor first reported a position in Supernus Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Supernus Pharmaceuticals position peaked at $133K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.